Disclosure under regulation 29(2) of SEBI(SAST) Regulations, 2011 received from Ishita Pharmaceuticals, related party of Ishita Drugs & Industries Ltd.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Pharmaceuticals, a promoter group / related party of Ishita Drugs & Industries Ltd, purchased 114 equity shares of Rs. 10 each through the open market on November 19, 2025. This is a negligible increase — holdings rose from 26,285 shares (0.88%) to 26,399 shares (0.88%) of the company's total share capital. The total equity share capital of the company stands at Rs. 2,99,03,000 (29,90,300 shares of Rs. 10 each). The disclosure was filed by the company to BSE on November 20, 2025.
This is a token acquisition with virtually no impact on promoter shareholding percentage or stock price. It signals continued promoter group interest but is too small to meaningfully affect ownership structure or trigger any regulatory threshold.